Cargando…

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study

BACKGROUND: Post-kala-azar dermal leishmaniasis (PKDL) is a common dermatological complication following successful treatment of Visceral Leishmaniasis (VL) caused by Leishmania donovani. PKDL presents as macular, papular, nodular or mixed skin rash on sun-exposed body parts. Patients are not ill un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abongomera, Charles, Gatluak, Francis, Buyze, Jozefine, Ritmeijer, Koert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033461/ https://www.ncbi.nlm.nih.gov/pubmed/27658288 http://dx.doi.org/10.1371/journal.pone.0163047

Ejemplares similares

Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
por: Kimutai, Robert, et al.
Publicado: (2017)

Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
por: Musa, Ahmed, et al.
Publicado: (2012)

Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2014)

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
por: Wiwanitkit, Viroj
Publicado: (2012)

Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination
por: Silva, Hermali, et al.
Publicado: (2021)

Assessment of serum amylase, lipase and associated factors among patients with visceral leishmaniasis treated with sodium stibogluconate/paromomycin at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia
por: Mengstie, Tiget Ayelgn, et al.
Publicado: (2021)

Transcriptional responses of Leishmania (Leishmania) amazonensis in the presence of trivalent sodium stibogluconate
por: Patino, Luz H., et al.
Publicado: (2019)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
por: Wasunna, Monique, et al.
Publicado: (2016)

Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell
por: Dar, M. Junaid, et al.
Publicado: (2018)

The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
por: Hussein, Nawfal R, et al.
Publicado: (2020)

LEISHMANIASIS OF THE LIP DIAGNOSED BY LYMPH NODE ASPIRATION AND TREATED WITH A COMBINATION OF ORAL KETACONAZOLE AND INTRALESIONAL SODIUM STIBOGLUCONATE
por: Vasudevan, Biju, et al.
Publicado: (2011)

High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2014)

“Kala-Azar is a Dishonest Disease”: Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan
por: Sunyoto, Temmy, et al.
Publicado: (2018)

Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in the Day-Case Management of Returned Travellers with New World Cutaneous Leishmaniasi
por: Wise, Emily S., et al.
Publicado: (2012)

Kala-azar and Post–Kala-azar Dermal Leishmaniasis, Assam, India
por: Khan, Abdul Mabood, et al.
Publicado: (2014)

Post Kala-azar Dermal Leishmaniasis
por: Das, Nilay Kanti
Publicado: (2020)

Correction: Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in the Day-Case Management of Returned Travellers with New World Cutaneous Leishmaniasis
por: Wise, Emily S., et al.
Publicado: (2012)

Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial
por: Tilahun Zewdu, Feleke, et al.
Publicado: (2022)

Treatment of Cutaneous Leishmaniasis with Sodium Stibogluconate and Allopurinol in a Routine Setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges
por: van Henten, Saskia, et al.
Publicado: (2023)

Treatment-Based Strategy for the Management of Post-Kala-Azar Dermal Leishmaniasis Patients in the Sudan
por: Musa, A. M., et al.
Publicado: (2013)

The Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Napier, L. Everard, et al.
Publicado: (1930)

Extensive Post-Kala-Azar Dermal Leishmaniasis
por: Dev, Tanvi, et al.
Publicado: (2018)

Dermoscopy of Post Kala-Azar Dermal Leishmaniasis
por: Jha, Abhijeet K., et al.
Publicado: (2018)

Biomarkers in Post-kala-azar Dermal Leishmaniasis
por: Zijlstra, Eduard E.
Publicado: (2019)

Epidemiology of Post-Kala-azar Dermal Leishmaniasis
por: Ghosh, Pramit, et al.
Publicado: (2021)

Histopathology of Post Kala-azar Dermal Leishmaniasis
por: Ramesh, V, et al.
Publicado: (2020)

The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia – A review and meta-analysis
por: Pijpers, Joyce, et al.
Publicado: (2019)

Evaluating the Efficacy of Combined Intralesional Sodium Stibogluconate Plus Topical Imiquimod on Healing and Risk of Scarring of Cutaneous Leishmaniasis: A Case-Control Study
por: Dhaher, Samer A, et al.
Publicado: (2022)

Post-Kala-Azar Dermal Leishmaniasis in Mymensingh, Bangladesh
por: Islam, Shamim, et al.
Publicado: (2011)

Post kala-azar dermal leishmaniasis: an unresolved mystery
por: Mukhopadhyay, Debanjan, et al.
Publicado: (2014)

An Unusual Case of Post-Kala-Azar Dermal Leishmaniasis
por: Gupta, P. C. Sen, et al.
Publicado: (1950)

Misdiagnosis and Mistreatment of Post-Kala-Azar Dermal Leishmaniasis
por: El Hassan, Ahmed Mohamed, et al.
Publicado: (2013)

A Case of Post-Kala-Azar Dermal Leishmaniasis
por: Dutta, S. C.
Publicado: (1951)

The immunology of post-kala-azar dermal leishmaniasis (PKDL)
por: Zijlstra, Eduard E.
Publicado: (2016)

A Case of Post-Kala-Azar Dermal Leishmaniasis
por: Dey, Nepal Chandra
Publicado: (1929)

A Case of Post-Kala-Azar Dermal Leishmaniasis
por: Dutta, J. C.
Publicado: (1953)

An Unusual Presentation of Post kala-azar Dermal Leishmaniasis
por: Pathania, Sucheta, et al.
Publicado: (2020)

Immune Responses in Post Kala-azar Dermal Leishmaniasis
por: Chatterjee, Mitali, et al.
Publicado: (2020)

Easy Test for Visceral Leishmaniasis and Post–Kala-azar Dermal Leishmaniasis
por: Saha, Samiran, et al.
Publicado: (2011)

A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan
por: Kämink, Suzette S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jngagk1j6rk1gs7jhds7fjp564